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The use of formalin fixed paraffin embedded (FFPE) tis-
sues for DNA analysis has been met with great difficul-
ties due to the degradative effect this fixation,
processing and storage has on DNA quality. The lack of
as u i t a b l ep r o t o c o lt oe n h a n c et h eq u a l i t yo fs u c h
degraded DNA has been a great hindrance to our ability
to make full use of clinically annotated FFPE cancer tis-
sue banks. In this report we have begun to investigate
the effectiveness and limitations to Illumina’s recent
platform for the restoration of DNA derived from archi-
val FFPE tissues.
With the exception of select fresh frozen and blood
samples, all DNA samples were extracted from FFPE tis-
sues and restored according to Illumina’sp r o t o c o l .T h e
quality of the FFPE extracted DNA was then assessed by
Illumina’sP C R - b a s e dq u a l i t yc o n t r o la s s a y( Q C - P C R )
and the resultant DNA was subsequently run on Illumi-
na’s SNP-based CGH chips. Chip call rates were largely
used in order to determine the quality of a particular
array. Overall, the chip data were highly reproducible as
determined by comparing several technical replicate
samples. FFPE-extracted and restored DNA performed
well in comparison to DNA extracted from fresh frozen
tumor and blood from the same patients, meeting the
minimum standard for continuation of this platform. It
should also be noted that the quality of the chip data
was not appreciably enhanced by the use of sodium
thiocyanate during the extraction of DNA from FFPE
tissues. Moreover, chip quality was significantly lower,
with regards to call rates and ‘quality’ of b allele
frequency plots, when the recommended Roche DNA
extraction kit was used instead of the Qiagen DNA
extraction kit. Of great importance, we found that the
QC-PCR provided an accurate prediction of chip quality
as determined by comparing chip call rates with PCR
signals derived from proprietary primer sets (rho=
0.6242, p<0.0001). The selection of restored DNA for
future studies will be guided by the results from the
QC-PCR assay.
These preliminary data demonstrate the promise of
Illumina’s DNA restoration protocol for FFPE extracted
DNA from tissues older than three decades. Further stu-
dies are required to determine the full potential of this
method for SNP-based CGH analysis of large FFPE
tumor banks.
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